Counteracting aldosterone in cardiorenal disease in type 2 diabetes through finerenone administration

被引：0
|
作者：
Ruilope, L. M. [1 ,2 ,3 ]
Ruiz-Hurtado, G. [1 ,2 ]
机构：
[1] Hosp Univ 12 Octubre, Inst Res I 12, Cardiorenal Translat Lab, Madrid, Spain
[2] Hosp Univ 12 Octubre, CIBER CV, Madrid, Spain
[3] European Univ Madrid, Sch Doctoral Studies & Res, Madrid, Spain
来源：
HIPERTENSION Y RIESGO VASCULAR | 2023年 / 40卷 / 02期
关键词：
CHRONIC KIDNEY-DISEASE; MINERALOCORTICOID RECEPTOR;
D O I：
10.1016/j.hipert.2022.11.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：55 / 57
页数：3
相关论文
共 50 条
  • [1] Blood pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes
    Ruilope, Luis M.
    Agarwal, Rajiv
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Rossing, Peter
    Sarafidis, Pantelis
    Schmieder, Roland E.
    Joseph, Amer
    Rethemeier, Nicole
    Nowack, Christina
    Bakris, George L.
    [J]. HYPERTENSION, 2022, 79 (12) : 2685 - 2695
  • [2] Cardiorenal and safety outcomes with finerenone in patients with obesity, CKD and type 2 diabetes
    Billings, L. K.
    Anker, S. D.
    Bakris, G. L.
    Filippatos, G.
    Pitt, B.
    Ruilope, L.
    Green, J.
    Mosenzon, O.
    Pantalone, K. M.
    Ahlers, C.
    Lage, A.
    Lawatscheck, R.
    Scalise, A.
    Rossing, P.
    [J]. DIABETOLOGIA, 2022, 65 (SUPPL 1) : S317 - S317
  • [3] Long-term cardiorenal efficacy of finerenone in patients with chronic kidney disease and type 2 diabetes
    Qiu, Mei
    Zhao, Li-Min
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (10) : 11239 - 11241
  • [4] Finerenone cardiorenal effects and its placement in treatment of chronic kidney disease in patients with type 2 diabetes mellitus: A review
    Salukhov, Vladimir V.
    Shamkhalova, Minara S.
    Duganova, Alla, V
    [J]. TERAPEVTICHESKII ARKHIV, 2023, 95 (03): : 261 - 273
  • [5] Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
    Pitt, Bertram
    Filippatos, Gerasimos
    Agarwal, Rajiv
    Anker, Stefan D.
    Bakris, George L.
    Rossing, Peter
    Joseph, Amer
    Kolkhof, Peter
    Nowack, Christina
    Schloemer, Patrick
    Ruilope, Luis M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (24): : 2252 - 2263
  • [6] Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes
    Makembi, Arriel B.
    Mohamadou, Inna
    Galichon, Pierre
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (11):
  • [7] A LEADER in the management of type 2 diabetes and cardiorenal disease
    Verma, Subodh
    Leiter, Lawrence A.
    Latter, David A.
    Bhatt, Deepak L.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 159 (03): : 978 - 984
  • [8] Cardiorenal Outcomes with Finerenone in Asian Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD post hoc Analysis
    Koya, Daisuke
    Anker, Stefan D.
    Ruilope, Luis M.
    Rossing, Peter
    Liu, Zhihong
    Lee, Byung Wan
    Lee, Chien-Te
    Scott, Charlie
    Kolkhof, Peter
    Lawatscheck, Robert
    Wang, Lili
    Joseph, Amer
    Pitt, Bertram
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2023, 54 (9-10) : 370 - 378
  • [9] Finerenone in chronic kidney disease and type 2 diabetes: the known and the unknown
    Fu, Edouard L.
    Kutz, Alexander
    Desai, Rishi J.
    [J]. KIDNEY INTERNATIONAL, 2023, 103 (01) : 30 - 33
  • [10] Finerenone in patients with chronic kidney disease and type 2 diabetes mellitus
    Wanner, C.
    Nitschmann, S.
    [J]. INTERNIST, 2021, 62 (05): : 577 - 580
12345